Search Results - "Druart, Celine"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Modulation of the Gut Microbiota by Nutrients with Prebiotic and Probiotic Properties by Druart, Céline, Alligier, Maud, Salazar, Nuria, Neyrinck, Audrey M., Delzenne, Nathalie M.

    Published in Advances in nutrition (Bethesda, Md.) (01-09-2014)
    “…Experimental data in animals, but also observational studies in humans, suggest that the composition of the gut microbiota differs in obese vs. lean…”
    Get full text
    Journal Article
  8. 8

    Gut Microbiome Integration in Drug Discovery and Development of Small Molecules by Jimonet, Patrick, Druart, Céline, Blanquet-Diot, Stéphanie, Boucinha, Lilia, Kourula, Stephanie, Le Vacon, Françoise, Maubant, Sylvie, Rabot, Sylvie, Van de Wiele, Tom, Schuren, Frank, Thomas, Vincent, Walther, Bernard, Zimmermann, Michael

    Published in Drug metabolism and disposition (01-04-2024)
    “…Human microbiomes, particularly in the gut, could have a major impact on the efficacy and toxicity of drugs. However, gut microbial metabolism is often…”
    Get full text
    Journal Article
  9. 9

    Ability of the gut microbiota to produce PUFA‐derived bacterial metabolites: Proof of concept in germ‐free versus conventionalized mice by Druart, Céline, Bindels, Laure B, Schmaltz, Robert, Neyrinck, Audrey M, Cani, Patrice D, Walter, Jens, Ramer‐Tait, Amanda E, Delzenne, Nathalie M

    Published in Molecular nutrition & food research (01-08-2015)
    “…SCOPE: The gut microbiota is able to modulate host physiology through the production of bioactive metabolites. Our recent studies suggest that changes in gut…”
    Get full text
    Journal Article
  10. 10

    Gut Microbial Metabolites of Polyunsaturated Fatty Acids Correlate with Specific Fecal Bacteria and Serum Markers of Metabolic Syndrome in Obese Women by Druart, Céline, Dewulf, Evelyne M., Cani, Patrice D., Neyrinck, Audrey M., Thissen, Jean-Paul, Delzenne, Nathalie M.

    Published in Lipids (01-04-2014)
    “…The aim of this human study was to assess the influence of prebiotic-induced gut microbiota modulation on PUFA-derived bacterial metabolites production…”
    Get full text
    Journal Article
  11. 11

    Adipose tissue adaptive response to trans‐10, cis‐12‐conjugated linoleic acid engages alternatively activated M2 macrophages by Pini, Maria, Touch, Sothea, Poirier, Helene, Dalmas, Elise, Niot, Isabelle, Rouault, Christine, Druart, Celine, Delzenne, Nathalie, Clément, Karine, André, Sebastien, Guerre‐Millo, Michele

    Published in The FASEB journal (01-01-2016)
    “…ABSTRACT In mice, nutritional supplementation with the trans‐10,cis‐12 isomer of linoleic acid (t10,c12‐CLA) promotes lipoatrophy, hyperinsulinemia, and…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Endocannabinoids — at the crossroads between the gut microbiota and host metabolism by Cani, Patrice D., Plovier, Hubert, Van Hul, Matthias, Geurts, Lucie, Delzenne, Nathalie M., Druart, Céline, Everard, Amandine

    Published in Nature reviews. Endocrinology (01-03-2016)
    “…Key Points As gut microorganisms interact with host cells via several mechanisms, targeting the microbiota to treat metabolic disorders is an attractive…”
    Get full text
    Journal Article
  14. 14

    Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice by Neyrinck, Audrey M, Possemiers, Sam, Druart, Céline, Van de Wiele, Tom, De Backer, Fabienne, Cani, Patrice D, Larondelle, Yvan, Delzenne, Nathalie M

    Published in PloS one (09-06-2011)
    “…Alterations in the composition of gut microbiota--known as dysbiosis--has been proposed to contribute to the development of obesity, thereby supporting the…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Postbiotics in the medical field under the perspective of the ISAPP definition: scientific, regulatory, and marketing considerations by Vinderola, Gabriel, Druart, Céline, Gosálbez, Luis, Salminen, Seppo, Vinot, Nina, Lebeer, Sarah

    Published in Frontiers in pharmacology (08-09-2023)
    “…Diverse terms have been used in the literature to refer to the health benefits obtained from the administration of non-viable microorganisms or their cell…”
    Get full text
    Journal Article
  18. 18

    Gut–Kidney Axis Investigations in Animal Models of Chronic Kidney Disease by Bartochowski, Piotr, Gayrard, Nathalie, Bornes, Stéphanie, Druart, Céline, Argilés, Angel, Cordaillat-Simmons, Magali, Duranton, Flore

    Published in Toxins (01-09-2022)
    “…Chronic kidney disease (CKD) is an incurable disease in which renal function gradually declines, resulting in no noticeable symptoms during the early stages…”
    Get full text
    Journal Article
  19. 19

    Role of the lower and upper intestine in the production and absorption of gut microbiota-derived PUFA metabolites by Druart, Céline, Neyrinck, Audrey M, Vlaeminck, Bruno, Fievez, Veerle, Cani, Patrice D, Delzenne, Nathalie M

    Published in PloS one (27-01-2014)
    “…In vitro studies have suggested that isolated gut bacteria are able to metabolize PUFA into CLA (conjugated linoleic acids) and CLnA (conjugated linolenic…”
    Get full text
    Journal Article
  20. 20

    Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome by Depommier, Clara, Everard, Amandine, Druart, Céline, Maiter, Dominique, Thissen, Jean-Paul, Loumaye, Audrey, Hermans, Michel P., Delzenne, Nathalie M., de Vos, Willem M., Cani, Patrice D.

    Published in Gut microbes (01-01-2021)
    “…Reduction of A. muciniphila relative abundance in the gut microbiota is a widely accepted signature associated with obesity-related metabolic disorders. Using…”
    Get full text
    Journal Article